Early pregnancy factor
A protein associated with early stages of pregnancy
Early pregnancy factor (EPF) is a protein that is secreted shortly after fertilization and is associated with the early stages of pregnancy. It is an immunosuppressive protein that plays a crucial role in the establishment and maintenance of pregnancy.
Discovery and Function[edit | edit source]
EPF was first identified in the 1970s as a factor present in the serum of pregnant women and animals shortly after conception. It is produced by the ovary and the embryo and can be detected within 24 to 48 hours after fertilization.
The primary function of EPF is to modulate the immune response of the mother to prevent the rejection of the embryo, which is genetically distinct from the mother. EPF achieves this by altering the activity of lymphocytes, which are a type of white blood cell involved in the immune response.
Mechanism of Action[edit | edit source]
EPF acts by binding to specific receptors on the surface of lymphocytes, leading to changes in their function. This binding inhibits the normal immune response that would otherwise target the embryo as a foreign body. The exact molecular pathways involved in EPF's action are still under investigation, but it is known to involve the modulation of cytokine production and the suppression of natural killer cells.
Clinical Significance[edit | edit source]
The presence of EPF in the blood can be used as an early marker of pregnancy. It is one of the earliest indicators of successful fertilization and implantation. However, the detection of EPF is not commonly used in clinical practice due to the availability of other pregnancy tests that are easier to administer.
Research into EPF also holds potential for understanding autoimmune diseases and transplant rejection, as its immunosuppressive properties could be harnessed for therapeutic purposes.
Research and Future Directions[edit | edit source]
Ongoing research is focused on understanding the detailed molecular structure of EPF and its receptor interactions. There is also interest in developing synthetic analogs of EPF that could be used to treat immune-related conditions.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
